Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jeffrey Lehrman

Podiatrist, Foot & Ankle Surgery Fort Collins, CO Doctor of Podiatric Medicine

NPI 1285721266 CMS profile 1139472

2001 S Shields St Ste F, Fort Collins, CO 80526

Open in the dashboard

General payments

$627,815

757 records reported · program years 2019–2025

Research payments

$106,257

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$750 paid to institutions, not to them · program year 2025

Through program year 2025, Jeffrey Lehrman of Fort Collins, CO is reported in the CMS Open Payments database as having received $627,815 across 757 general payments and $106,257 in research payments paid to them. Separately, studies naming them as principal investigator received $750 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $41,119 54
2024 General $90,860 130
2024 Research $911 3
2023 General $74,740 148
2022 General $130,521 149
2021 General $147,289 82
2021 Research $1,623 3
2020 General $54,981 69
2020 Research $103,723 3
2019 General $88,304 125

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jeffrey Lehrman
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Jeffrey Lehrman were reported at $41,119. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Jeffrey Lehrman Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $88,304 $389 $118–$1,406 $163
2020 $54,981 $191 $62–$691 $114
2021 $147,289 $329 $104–$1,341 $132
2022 $130,521 $419 $125–$1,611 $149
2023 $74,740 $377 $128–$1,164 $160
2024 $90,860 $394 $134–$1,168 $164
2025 $41,119 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organogenesis Inc. $217,313 413 payments
  2. Orpyx Medical Technologies Inc. $154,630 33 payments
  3. Smith+Nephew, Inc. $96,624 134 payments
  4. Modulated Imaging, Inc. $72,902 36 payments
  5. Endo USA, Inc. $24,745 2 payments
  6. Spinal Simplicity, LLC $19,970 46 payments
  7. Tenex Health Inc. $10,458 22 payments
  8. Kerecis Limited $10,087 9 payments
  9. Treace Medical Concepts, Inc. $7,069 20 payments
  10. Trice Medical, Inc. $6,737 23 payments
  11. Other $7,280 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $325,787 194 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $207,747 111 payments
  3. Travel and Lodging $49,389 287 payments
  4. Honoraria $13,800 12 payments
  5. Education $13,667 10 payments
  6. Current or prospective ownership or investment interest $7,300 1 payment
  7. Food and Beverage $7,230 139 payments
  8. Compensation for serving as faculty or as a speaker for a medical education program $2,895 3 payments
Products named General payments · program years 2019–2025
  1. Orpyx SI $147,432 24 payments
  2. Puraply $81,338 147 payments
  3. Clarifi Imaging System $72,902 36 payments
  4. PURAPLY WOUND MATRIX $65,150 124 payments
  5. Affinity $61,750 132 payments
  6. NuShield $49,930 104 payments
  7. APLIGRAF Wound Care $49,930 104 payments
  8. NOVACHOR $49,930 104 payments
  9. COLLAGENASE SANTYL $42,237 72 payments
  10. Apligraf Podiatry $37,256 80 payments
  11. Other $304,358 432 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Endo Pharmaceuticals Inc. $105,345 6 payments
  2. Treace Medical Concepts, Inc. $911 3 payments

Billing to Medicare

Part B · data year 2024 · 17 billing codes

Paid by Medicare

$15,667

Medicare's payments for the services billed

Medicare patients

121

Average age 77

Services billed

422

57 women, 64 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 53%
Diabetes 35%
Chronic kidney disease 31%
Ischemic heart disease 29%
Depression 29%
Heart failure 23%
Atrial fibrillation 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

766 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record